Outlook Therapeutics
OTLK----
Q2 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Outlook Therapeutics(OTLK) predict that the Revenue is 127.44 K (--%), Miss estimate;the EBIT is -14.03 M (-13.2%), Miss estimate;the EPS is -0.05 (+96.67%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.00B--
0.00B--
-0.00B--%
EBITMiss expectations
-0.01B13.20%
-0.01B16.41%
-0.00B29.61%
EPSExceed expectations
-0.0596.67%
-0.1192.67%
+0.06004.00%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf